Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Table 1

Patient characteristics.

Case	Age	Sex	Diagnosis	Cytogenetics	IPSS	Blast (%)
1	61	Male	RUMD	Normal	0.5	0.5
2	59	Male	RUMD	Normal	0.5	0
3	54	Female	5q- syndrome	5q-	0.5	1
4	56	Female	RAEB I	+8,20q-	1.5	8
5	64	Male	RA	20q-	0.5	1.5
6	84	Male	RAEB II	Normal	2.0	16
7	38	Male	RAEB II	−9,−11,+8	3.0	17
8	21	Male	RUMD	Normal	0.5	2.5
9	50	Male	RAEB II	+8,20q-	2.5	14
10	27	Male	RT	+8	0	1
11	50	Female	RAEB II	+8,20q-	2.0	17
12	50	Male	RARS	+8	0	0.5
13	58	Female	RAEB II	5q-,7q-,20q-	3	18
14	61	Male	5q- syndrome	5q-	0.5	1
15	62	Female	RARS	Normal	0	1.5
16	58	Female	RAEB II	7q-,−12,−13	3.0	12.5
17	37	Male	RAEB I	+8,−Y	1.0	7
18	30	Male	RUMD	+8	0.5	1
19	69	Female	RAEBI	+8,−12	1.0	6.5
20	68	Male	RAEB II	7q-	2.0	10
21	33	Male	RARS	Normal	0	0.5
22	38	Male	RAEB II	+8,20q-	2.5	12.5
23	79	Female	RAEB II	Normal	2.0	12.5
24	58	Male	RAEB I	Normal	1.0	8.5
25	62	Male	RUMD	5q-,20q-	1.0	1
26	53	Female	RAEB II	−14	2.5	11
27	29	Female	RAEB II	Normal	2.0	16
28	70	Female	RAEB II	−7,−14	3.0	13
29	49	Female	RARS	Normal	0	0.5
30	53	Male	RAEB I	−7,−13	2.0	6
31	59	Female	RAEB I	5q-,+8,−12	1.5	6
32	64	Male	RUMD	Normal	0.5	1.5
33	67	Female	RUMD	+8,20q-,7q-	1.5	2.5
34	66	Male	RAEB II	−7	3	13
35	63	Male	RAEB II	Normal	2.0	17
36	42	Female	RARS	+8,20q-	0.5	0
37	55	Male	RUMD	7q-	1.5	4.5
38	51	Female	RARS	Normal	0	0
39	56	Male	5q- syndrome	5q-	0.5	1.5
40	64	Female	RA	Normal	0	0.5
41	65	Female	RA	Normal	0	0
42	76	Male	RAEB I	7q-	2	6.5

Cases numbered 8 to 42 were enrolled in our whole experiment while cases numbered 1 to 7 only volunteered in the ELISA and RT-PCR parts.